GNI Group Ltd. 2160Short Interest
Estimated short interest in GNI Group Ltd. (2160) is 11.16% of shares outstanding as of 2026-11-18. Institutions holding 0.5% or more: Morgan Stanley MUFG Securities Co., Ltd., MERRILL LYNCH INTERNATIONAL, Barclays Capital Securities Ltd and 4 others.
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It excludes 2 institutions whose last report is more than a year old (1.85% in total). It also excludes 18 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2017-08-31 |
|---|---|
| Latest disclosure | 2026-11-17 (Morgan Stanley MUFG Securities Co., Ltd., 4.67%) |
| Reporting institutions | 30 firms (3124 reports) |
| Peak estimated short interest | 13.12% (2023-08-07, 7 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 5 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- Morgan Stanley MUFG Securities Co., Ltd.
- MERRILL LYNCH INTERNATIONAL
- Barclays Capital Securities Ltd
- Arrowstreet Capital, Limited Partnership
- Nomura International plc
- Others
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2026-11-17 | Morgan Stanley MUFG Securities Co., Ltd. | Position 3,078,662 shares | Ratio 4.67% | ▼0.10% | Holding |
| 2026-11-16 | MERRILL LYNCH INTERNATIONAL | Position 1,326,522 shares | Ratio 2.01% | ▲0.08% | Holding |
| 2026-11-16 | Barclays Capital Securities Ltd | Position 1,006,100 shares | Ratio 1.52% | ▲0.14% | Holding |
| 2017-10-03 | JPMorgan Securities Japan Co., Ltd. | Position 1,824,847 shares | Ratio 1.35% | ▲0.15% | No report for 1+ year |
| 2026-06-30 | Arrowstreet Capital, Limited Partnership | Position 585,550 shares | Ratio 0.88% | ▼0.14% | Holding |
| 2026-11-16 | Nomura International plc | Position 521,664 shares | Ratio 0.79% | ▼0.18% | Holding |
| 2026-11-13 | GOLDMAN SACHS INTERNATIONAL | Position 486,671 shares | Ratio 0.73% | ▼0.12% | Holding |
| 2026-11-16 | Citigroup Global Markets Limited | Position 374,328 shares | Ratio 0.56% | ▼0.12% | Holding |
| 2024-08-27 | Arrowstreet Capital Global Equity Long/Short Fund | Position 251,500 shares | Ratio 0.50% | ▲0.10% | No report for 1+ year |
| 2026-01-29 | D. E. Shaw & Co. (Asia Pacific) Limited | Position 275,000 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
| 2026-03-13 | UBS AG | Position 272,093 shares | Ratio 0.48% | ▼0.18% | Below 0.5% |
| 2019-11-28 | Credit Suisse Securities (Japan) Limited | Position 203,700 shares | Ratio 0.47% | ▼0.07% | Below 0.5% |
| 2023-12-28 | Segregated Portfolio D | Position 238,100 shares | Ratio 0.47% | ▼0.20% | Below 0.5% |
| 2025-02-07 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 238,090 shares | Ratio 0.47% | ▼0.13% | Below 0.5% |
| 2018-12-27 | Alt Beta Equity Size Strategy Limited | Position 63,399 shares | Ratio 0.46% | ▼0.11% | Below 0.5% |
| 2017-12-29 | Bogle Offshore Opportunity Fund II, Ltd. | Position 605,541 shares | Ratio 0.44% | ▼0.10% | Below 0.5% |
| 2023-11-27 | Arrowstreet ACWI ex US Alpha Extension Trust Fund U | Position 214,700 shares | Ratio 0.43% | ▼0.10% | Below 0.5% |
| 2025-05-30 | Barclays Bank PLC | Position 220,674 shares | Ratio 0.43% | ▼0.09% | Below 0.5% |
| 2025-07-03 | Numeric Investors LLC | Position 220,900 shares | Ratio 0.43% | ▼0.15% | Below 0.5% |
| 2020-09-04 | JANE STREET GLOBAL TRADING, LLC | Position 185,700 shares | Ratio 0.42% | ▼0.17% | Below 0.5% |
| 2026-11-10 | JPM Securities Japan Co Ltd. | Position 263,092 shares | Ratio 0.39% | ▼0.13% | Below 0.5% |
| 2019-11-22 | Credit Suisse Securities (Europe) Limited | Position 158,677 shares | Ratio 0.36% | ▼0.14% | Below 0.5% |
| 2026-11-04 | Qube Research & Technologies Limited | Position 240,323 shares | Ratio 0.36% | ▼0.15% | Below 0.5% |
| 2023-10-03 | Diversified Select Opportunities Capital Management, LLC | Position 166,400 shares | Ratio 0.35% | ▼0.24% | Below 0.5% |
| 2021-03-18 | Credit Suisse AG | Position 150,000 shares | Ratio 0.32% | ▼0.24% | Below 0.5% |
| 2025-04-08 | JANE STREET SINGAPORE PTE. LIMITED | Position 164,468 shares | Ratio 0.32% | ▼0.44% | Below 0.5% |
| 2026-11-06 | Societe Generale | Position 216,393 shares | Ratio 0.32% | ▼0.30% | Below 0.5% |
| 2020-03-19 | Deutsche Bank Aktiengesellschaft, London | Position 0 shares | Ratio 0.00% | ▼0.60% | Closed |
| 2026-06-10 | Nomura Securities Co., Ltd. | Position 0 shares | Ratio 0.00% | ▼0.57% | Closed |
| 2026-07-29 | SMBC Nikko Securities Inc. | Position 0 shares | Ratio 0.00% | ▼0.65% | Closed |
Disclosure History 3124 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2026-11-17 | Morgan Stanley MUFG Securities Co., Ltd. | Position 3,078,662 shares | Ratio 4.67% | ▼0.10% | — |
| 2026-11-16 | Nomura International plc | Position 521,664 shares | Ratio 0.79% | ▼0.18% | — |
| 2026-11-16 | MERRILL LYNCH INTERNATIONAL | Position 1,326,522 shares | Ratio 2.01% | ▲0.08% | — |
| 2026-11-16 | Citigroup Global Markets Limited | Position 374,328 shares | Ratio 0.56% | ▼0.12% | — |
| 2026-11-16 | Barclays Capital Securities Ltd | Position 1,006,100 shares | Ratio 1.52% | ▲0.14% | — |
| 2026-11-16 | Morgan Stanley MUFG Securities Co., Ltd. | Position 3,143,962 shares | Ratio 4.77% | ▲0.56% | — |
| 2026-11-13 | MERRILL LYNCH INTERNATIONAL | Position 1,273,722 shares | Ratio 1.93% | ▼0.10% | — |
| 2026-11-13 | GOLDMAN SACHS INTERNATIONAL | Position 486,671 shares | Ratio 0.73% | ▼0.12% | — |
| 2026-11-13 | Citigroup Global Markets Limited | Position 449,128 shares | Ratio 0.68% | ▼0.02% | — |
| 2026-11-13 | Barclays Capital Securities Ltd | Position 914,400 shares | Ratio 1.38% | ▲0.23% | — |
| 2026-11-13 | Morgan Stanley MUFG Securities Co., Ltd. | Position 2,772,462 shares | Ratio 4.21% | ▲0.19% | — |
| 2026-11-12 | Morgan Stanley MUFG Securities Co., Ltd. | Position 2,649,662 shares | Ratio 4.02% | ▲0.16% | — |
| 2026-11-12 | Nomura International plc | Position 640,529 shares | Ratio 0.97% | ▼0.15% | — |
| 2026-11-12 | MERRILL LYNCH INTERNATIONAL | Position 1,337,522 shares | Ratio 2.03% | ▼0.02% | — |
| 2026-11-11 | Nomura International plc | Position 739,100 shares | Ratio 1.12% | ▲0.03% | — |
| 2026-11-11 | MERRILL LYNCH INTERNATIONAL | Position 1,351,622 shares | Ratio 2.05% | ▼0.05% | — |
| 2026-11-11 | Citigroup Global Markets Limited | Position 463,228 shares | Ratio 0.70% | ▲0.01% | — |
| 2026-11-11 | Morgan Stanley MUFG Securities Co., Ltd. | Position 2,544,162 shares | Ratio 3.86% | ▲0.14% | — |
| 2026-11-10 | Nomura International plc | Position 721,242 shares | Ratio 1.09% | ▼0.05% | — |
| 2026-11-10 | MERRILL LYNCH INTERNATIONAL | Position 1,387,322 shares | Ratio 2.10% | ▼0.08% | — |
| 2026-11-10 | JPM Securities Japan Co Ltd. | Position 263,092 shares | Ratio 0.39% | ▼0.13% | Below 0.5% |
| 2026-11-10 | GOLDMAN SACHS INTERNATIONAL | Position 560,271 shares | Ratio 0.85% | ▼0.10% | — |
| 2026-11-10 | Citigroup Global Markets Limited | Position 458,628 shares | Ratio 0.69% | ▼0.04% | — |
| 2026-11-10 | Barclays Capital Securities Ltd | Position 761,926 shares | Ratio 1.15% | ▼0.11% | — |
| 2026-11-09 | Nomura International plc | Position 751,452 shares | Ratio 1.14% | ▼0.14% | — |
| 2026-11-09 | MERRILL LYNCH INTERNATIONAL | Position 1,437,822 shares | Ratio 2.18% | ▼0.21% | — |
| 2026-11-09 | JPM Securities Japan Co Ltd. | Position 343,292 shares | Ratio 0.52% | ▲0.12% | — |
| 2026-11-09 | GOLDMAN SACHS INTERNATIONAL | Position 632,071 shares | Ratio 0.95% | ▼0.11% | — |
| 2026-11-09 | Citigroup Global Markets Limited | Position 483,228 shares | Ratio 0.73% | ▲0.04% | — |
| 2026-11-09 | Barclays Capital Securities Ltd | Position 830,600 shares | Ratio 1.26% | ▼0.07% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |
| Renascience Inc.4889 | 6.87% | 3 firms |
Related Stocks Same TSE 33 sector
| Stock | Market | TSE 33 Sector | TOPIX-17 Sector | Index |
|---|---|---|---|---|
| Veritas In Silico Inc.130A | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Chordia Therapeutics Inc.190A | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| TAUNS Laboratories,Inc.197A | Standard Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| PRISM BioLab Co.,LTD206A | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Heartseed Inc.219A | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Kyowa Kirin Co.,Ltd.4151 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Mid400 |
| Takeda Pharmaceutical Company Limited4502 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Core30 |
| Astellas Pharma Inc.4503 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Large70 |
| Sumitomo Pharma Co.,Ltd.4506 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Mid400 |
| J-Pharma Co.,Ltd.520A | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical |